Lexipafant

DB20750ExperimentalSmall molecule

Lexipafant is a small molecule drug. The usage of the INN stem '-pafant' in the name indicates that Lexipafant is a platelet-activating factor antagonist. Lexipafant has a monoisotopic molecular weight...

Formula / weight: C₂₃H₃₀N₄O₄S · 458.58 g/mol (avg)
Code names: BB-882

Resolves to

Compound

UNIIH14917M9YWCAS139133-26-9ChEMBLCHEMBL322832ChEBI748436PubChem9804204

Structure

InChIKeyAQRXDPFOYJSPMP-QFIPXVFZSA-NSMILESCCOC(=O)[C@H](CC(C)C)N(C)S(=O)(=O)C1=CC=C(CN2C(C)=NC3=CN=CC=C23)C=C1

Targets

P25105PTAFRP03366gag-pol

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Lexipafant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account